Associated Papers
Role of the mitochondrial regulatory factor CHCHD2 in neurodegenerative diseases.
Guo X et al.
Frontiers in Neuroscience, 2025
Antiapoptotic Gene Genotype and Allele Variations and the Risk of Lymphoma.
Al-Amer OM et al.
Cancers, 2023
36831357 (PubMed )
Supplement: cancers-15-01012-s001.zip › Table_S2.pdf
Benchmarking of SpCas9 variants enables deeper base editor screens of BRCA1 and BCL2.
Sangree AK et al.
Nature Communications, 2022
35288574 (PubMed )
Supplement: 41467_2022_28884_MOESM11_ESM.xlsx › NG-CBE_Library_Annotation
Docking-based approach for identification of mutations that disrupt binding between Bcl-2 and Bax proteins: Inducing apoptosis in cancer cells.
Raghav PK et al.
Molecular Genetics & Genomic Medicine, 2019
Mitochondrial CHCHD-Containing Proteins: Physiologic Functions and Link with Neurodegenerative Diseases.
Zhou ZD et al.
Molecular Neurobiology, 2017
Involvement of BH4 domain of bcl-2 in the regulation of HIF-1-mediated VEGF expression in hypoxic tumor cells.
Trisciuoglio D et al.
Cell Death and Differentiation, 2011
Structural conservation of residues in BH1 and BH2 domains of Bcl-2 family proteins.
Gurudutta GU et al.
Febs Letters, 2005
The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry.
Huang DC et al.
The Embo Journal, 1997
Activation of C. elegans cell death protein CED-9 by an amino-acid substitution in a domain conserved in Bcl-2.
Hengartner MO et al.
Nature, 1994
Select a paper to view details